Cytodyn Inc (CYDY)

[kgromax]

Proof that placebo beats Leronlimab:

this analysis proves that Leronlimab alone had a 35% mortality rate against placebo alone at 14% mortality, with a p-value of 7.5%.

Accepting Cytodyn results implies accepting this missing piece in the 8K data tables (conveniently NOT reported by Cytodyn): that placebo, or saline, beats Leronlimab.

So, finally, I do agree that Loserlimab is not saline. It's worse !!!

This company is a fraud.